Mahdi Garba (Lead Writer)In August 2023, Nigeria’s second-largest pharmaceutical company, GlaxoSmithKline (GSK), announced its exit from the country, ending its 51-year presence. Three months later, Sanofi, another leading pharmaceutical company, also announced their exit from Nigeria. The recurrent instability in the foreign exchange market and high manufacturing costs made it difficult for multinational companies to […]